Cognito nets $35 million to advance Alzheimer's DTx trial

Jan 29, 2024 · Cognito Therapeutics has raised $35 million to advance its digital therapeutic (DTx) for Alzheimer's disease, the company's CEO Brent Vaughan told FirstWord HealthTech …

CouponFollow Extension

$35
OFF

Cognito Nets $35 Million To Advance Alzheimer's DTx Trial

1 week from now

Jan 29, 2024 · Cognito Therapeutics has raised $35 million to advance its digital therapeutic (DTx) for Alzheimer's disease, the company's CEO Brent Vaughan told FirstWord HealthTech …

firstwordhealthtech.com

$35
OFF

Cognito Raises $35M, Launches Alzheimer’s Biomarker Study

1 week from now

Feb 1, 2024 · Cognito Therapeutics Inc. closed a $35 million extension to the series B fundraising round it started in 2023, bringing the total for the round to $108 million and the total funding to …

bioworld.com

$35
OFF

FirstWord HealthTech On LinkedIn: Cognito Nets $35 Million To …

1 week from now

Cognito Therapeutics, Inc. has raised $35 million to advance its digital ... Cognito nets $35 million to advance Alzheimer's DTx trial ... Decentralised trials firm Science 37 to go private in ...

linkedin.com

$73
OFF

Neuro Startup Cognito Corrals $73M As Alzheimer’s ... - MedCity …

1 week from now

Alzheimer’s disease research at MIT spawned Cognito Therapeutics, a startup whose medical device uses light and sound to modulate electrical activity that supports brain health. The …

medcitynews.com

FAQs about Cognito nets $35 million to advance Alzheimer's DTx trial Coupon?

Is Cognito a breakthrough drug for Alzheimer's disease?

Brent Vaughn, chief executive officer of Cognito Therapeutics, expressed excitement about the data announcement in a statement and added, “With our recent FDA breakthrough device designation, we look forward to expediting the clinical development of what has the promise to be the first disease-modifying digital therapeutic in Alzheimer’s disease.” ...

Can nutmeg cure dementia?

Nutmeg (Myristica fragrans) is widely used to flavour sweet and savoury foods and has been used as a herbal medicine to enhance appetite in Asian countries. In addition, a combination of nutmeg oil mixed with other medicinal plants shows positive effect on memory and learning by abating free radical and acetylcholine levels, and increased learning and memory, providing a strong rationale for its use in the treatment of dementia. Therefore, it´s not possible to cure dementia, but to ameliorate the disease´s symptoms. ...

Does Cognito help Alzheimer's patients?

Compared with the placebo group, those who got the Cognito stimulation showed a 77 percent slowing in functional decline as measured by a scale that assesses how well Alzheimer’s patients are able to carry out daily activities, such as eating, dressing, and getting around. ...

What is Cognito therapeutic's next-generation neurostimulation device?

Cognito Therapeutic’s next-generation neurostimulation device for treating Alzheimer’s symptoms wins breakthrough designation from the FDA. ...

How much money has Cognito raised?

The Series B financing was led by FoundersX Ventures. The round also added new investors Alzheimer’s Drug Discovery Foundation, Starbloom Capital, IAG Capital, and WS Investment Company. Since inception, Cognito says it has raised $93 million total. ...

What does the FDA do with Cognito?

Under the program, the FDA will provide Cognito with priority review and interactive communication regarding device development and clinical trial protocols, through to commercialization decisions. ...